- ►diabetesjournals.org A Mima, H Arai, T Matsubara, H Abe, K Nagai, Y … - Diabetes, 2008 - Am Diabetes Assoc OBJECTIVE—We reported that Smad1 is a key transcriptional factor for mesangial matrix expansion
in diabetic nephropathy. In this study, we examined whether urinary Smad1 in an early phase
of diabetes can predict later development of glomerulosclerosis in diabetic nephropathy ... Cited by 3 - Related articles - All 3 versions
A Mima, T Matsubara, H Arai, H Abe, K Nagai, H … - Laboratory …, 2006 - nature.com Angiotensin II (Ang II) is known to play a pivotal role in the development of diabetic
nephropathy. However, the precise mechanism of Ang II-mediated effects on diabetic nephropathy
is still unknown. We have reported that Smad1 plays a key role in diabetic mesangial ... Cited by 7 - Related articles - BL Direct - All 5 versions
JP Singh - Current Opinion in Investigational Drugs, 2007 - 万方数据资源系统 Nitric oxide (NO) has a key role in promoting angiogenesis by increasing vasodilation, vascular
permeability, endothelial cell proliferation and migration, and by modifying the activities of angiogenic
mediators. NO is also critical for the mobilization of endothelial progenitor cells from the ... Cited by 3 - Related articles - BL Direct - All 4 versions
L Rebsomen, A Khammar, D Raccah, M … - Experimental Diabetes …, 2008 - hindawi.com Page 1. Hindawi Publishing Corporation Experimental Diabetes Research Volume 2008, Article
ID 281536, 5 pages doi:10.1155/2008/281536 Review Article C-Peptide Effects on Renal
Physiology and Diabetes L. Rebsomen, A. Khammar, D. Raccah, and M. Tsimaratos ... Cited by 2 - Related articles - View as HTML - All 10 versions
- ►oxfordjournals.org N Joss, R Patel, K Paterson, K Simpson, C Perry, C … - QJM, 2007 - Oxford Univ Press Aim: To investigate the chronic kidney disease stage at which patients with diabetic nephropathy
are referred to renal services, determine the prevalence of anaemia in patients with diabetic
nephropathy, examine patient outcome and identity prognostic factors. Cited by 2 - Related articles - BL Direct - All 2 versions
- ►lava.med.br [PDF] M Hayashi - Clinical and experimental nephrology, 2006 - Springer Abstract The increasing number of patients on chronic hemodialysis is a great problem in the
field of nephrology in Japan and Western countries. Current therapies for chronic kidney diseases
(CKDs) can retard the progression of renal failure, but cannot completely stop their ... Cited by 2 - Related articles - BL Direct - All 5 versions
S Yoshida, T Hashimoto, M Kihara, N Imai, H … - Nephron Exp …, 2009 - content.karger.com Backgrounds/Aims: It has been reported that urinary oxidative stress markers are higher in diabetic
patients with proteinuria. We performed the present study to elucidate the relationship between
urinary excretion of oxidative stress markers, albumin excretion, and histological ... Cited by 2 - Related articles - All 4 versions
S Chen, FN Ziyadeh - Current Diabetes Reports, 2008 - Springer The field of vascular endothelial growth factor (VEGF) has recently witnessed a surge of research
into its role in diabetic kidney disease. Based on its credentials as a potent inducer of vasopermeability
and angiogenesis, podocyte-derived VEGF is believed to participate in the glomerular ... Cited by 4 - Related articles - All 2 versions
SM Bindom, E Lazartigues - Molecular and Cellular Endocrinology, 2009 - Elsevier Diabetes mellitus is a growing problem in all parts of the world. Both clinical trials and animal
models of type I and type II diabetes have shown that hyperactivity of angiotensin-II (Ang-II) signaling
pathways contribute to the development of diabetes and diabetic complications. Of ... Cited by 2 - Related articles - All 2 versions
